Number of shares and voting rights as at 31 December 2014


Number of shares and voting rights

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)


Press release

Avignon, January 16th, 2015



31.12.2014






Total number of outstanding shares forming the capital

- 9,196,225 ordinary shares under ISIN FR0000054694

- 362 shares issued from stock-options under ISIN FR0000054694
9,196,587


Number of shares with double voting rights
2,044,470


Total number of gross voting rights
11,241,057


Number of shares without voting rights

- 9,461 bearer shares in the frame of the liquidity contract
- 9,461


Total number of exercisable voting rights*
11,231,596


*Real number of voting rights = total number of voting rights – number of shares without voting rights




You can receive all financial information of Naturex free of charge by signing up at:

www.naturex.com



Financial schedule





- Annual revenue

- Annual results


3 February 2015

31 March 2015





Upcoming events




- SFAF analysts meeting (Paris)

2 April 2015




Naturex has been listed since October 1996 on Euronext in Paris, Segment B







Total number of shares comprising the share capital: 9,196,587 (December 2014)

ISIN FR0000054694

 

NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

 

TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY



About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia, India and Chili. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.



Contacts



Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

c.alexandre@naturex.com





Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

acbonjour@actus.fr
Thierry-Bertrand Lambert

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

t.b.lambert@naturex.com

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-
Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-38497-2015.01.16-Nb-of-shares-and-voting-rights_December-2014.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews